DiaMedica Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Note 11 - Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2022

	December 31, 2022
Employee and non-employee stock options		2,782,248
Common shares issuable upon settlement of deferred stock units		134,402
Common shares issuable under common share purchase warrants		265,000
Shares available for grant under the Amended and Restated 2019 Omnibus Incentive Plan		2,005,260
Shares available for grant under the 2021 Employment Inducement Incentive Plan		535,000
Total		5,721,910